export const manufacturersData = [
    {
        "manufacturerId": 1,
        "name": "Pfizer",
        "description": "Pfizer Inc. is a multinational pharmaceutical and biotechnology company headquartered in New York City. Established in 1849 by Charles Pfizer and Charles Erhart, it has grown to be one of the world's largest and most recognized pharmaceutical companies. Pfizer focuses on discovering, developing, and manufacturing medicines and vaccines for a variety of medical fields, including oncology, immunology, cardiology, and infectious diseases.",
        "details": {
            "founded": "1849",
            "headquarters": "New York City, U.S.",
            "ceo": "Dr. Albert Bourla",
            "revenue": "US $58.5 Billion",
            "operatingIncome": "US $2.17 Billion",
            "netIncome": "US $2.12 Billion",
            "totalAssets": "US $226.5 Billion",
            "totalEquity": "US $89.01 Billion",
            "numberOfEmployees": "88,000",
            "sources": [
                {
                    "lastUpdated": "2023",
                    "title": "Annual Report on Form 10-K",
                    "link": "https://s28.q4cdn.com/781576035/files/doc_financials/2023/ar/2023-10k.pdf"
                }
            ]
        },
        "vaccines": [
            {
                "vaccineId": 1
            },
            {
                "vaccineId": 3
            },
            {
                "vaccineId": 5
            },
            {
                "vaccineId": 6
            },
            {
                "vaccineId": 7
            },
            {
                "vaccineId": 8
            },
            {
                "vaccineId": 2
            },
            {
                "vaccineId": 4
            },
            {
                "vaccineId": 12
            }
        ],
        "link": "https://www.pfizer.com/products/product-list",
        "lastUpdated": "2024-Aug"
    },
    {
        "manufacturerId": 2,
        "name": "Johnson & Johnson",
        "description": "Johnson & Johnson engages in research and development, manufacture and sale of a broad range of products in the health care field. They are organized into three business segments: Consumer Health, Pharmaceutical and Medical Devices. With products sold in over 175 countries, Johnson & Johnson’s key pharmaceutical products include REMICADE®, SIMPONI®, SIMPONI ARIA®, STELARA®, DARZALEX®, IMBRUVICA®, etc. Johnson & Johnson also produces a COVID-19 vaccine: Janssen COVID-19 Vaccine.",
        "details": {
            "founded": "January 1886",
            "headquarters": "Johnson and Johnson Plaza, New Brunswick, New Jersey, U.S.",
            "ceo": "Joaquin Duato",
            "revenue": "US $85.16 Billion",
            "operatingIncome": "US $21.21 Billion",
            "netIncome": "US $35.15 Billion",
            "totalAssets": "US $167.6 Billion",
            "totalEquity": "US $68.78 Billion",
            "numberOfEmployees": "134,400",
            "sources": [
                {
                    "lastUpdated": "2023",
                    "title": "Johnson & Johnson From Wikipedia, the free encyclopedia",
                    "link": "https://en.wikipedia.org/wiki/Johnson_%26_Johnson"
                },
                {
                    "lastUpdated": "2021",
                    "title": "Johnson & Johnson Financial Statements 2005-2021",
                    "link": "https://www.macrotrends.net/stocks/charts/JNJ/johnson-johnson/financial-statements"
                },
                {
                    "lastUpdated": "2020",
                    "title": "Johnson & Johnson Annual Report 2020",
                    "link": "https://www.investor.jnj.com/annual-meeting-materials/2020-annual-report/"
                }
            ]
        },
        "vaccines": [
            {
                "vaccineId": 9
            }
        ],
        "lastUpdated": "2024-Aug"
    },
    {
        "manufacturerId": 3,
        "name": "GlaxoSmithKline",
        "description": "GlaxoSmithKline (GSK) is a multinational pharmaceutical company with a purpose to improve the quality of human life by helping people do more, feel better, and live longer. GSK is organized into three business segments: pharmaceuticals, vaccines, and consumer healthcare. GSK operates in more than 150 countries with employees across 96 markets. Key products include Bexsero, Fluarix/FluLaval, Shingrix, Boostrix, Synflorix, Rotarix, Infanrix, Pediarix, Hepatitis vaccine, etc.",
        "details": {
            "founded": "27 December 2000",
            "headquarters": "London, England, UK",
            "ceo": "Emma Walmsley",
            "revenue": "£30.328 Billion",
            "operatingIncome": "£6.745 Billion",
            "netIncome": "£5.308 Billion",
            "totalAssets": "£59.005 Billion",
            "totalEquity": "£12.795 Billion",
            "numberOfEmployees": "70,000",
            "sources": [
                {
                    "lastUpdated": "2023",
                    "title": "GSK plc From Wikipedia, the free encyclopedia",
                    "link": "https://en.wikipedia.org/wiki/GSK_plc"
                },
                {
                    "lastUpdated": "2020",
                    "title": "Full year and fourth quarter 2020 report",
                    "link": "https://www.gsk.com/media/6557/fy-2020-results-announcement.pdf"
                },
                {
                    "lastUpdated": "2020",
                    "title": "GSK Key Facts",
                    "link": "https://www.gsk.com/en-gb/company/gsk-at-a-glance/"
                }
            ]
        },
        "vaccines": [
            {}
        ],
        "lastUpdated": "2024-Aug"
    },
    {
        "manufacturerId": 4,
        "name": "Merck & Co., Inc.",
        "description": "Merck & Co., Inc. is a global health care company that delivers innovative health solutions through its prescription medicines, vaccines, biologic therapies, and animal health products. Merck operates in two segments: Pharmaceutical and Animal Health segments. The Pharmaceutical segment includes human health pharmaceutical and vaccine products while the Animal Health segment discovers, develops, manufactures and markets a wide range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all major livestock and companion animal species. Merck operates in more than 140 countries worldwide with key products such as Gardasil, Varivax, Pneumovax, ProQuad, M-M-R II, etc.",
        "details": {
            "founded": "January 1891 (as a subsidiary of Merck) 1917 (as an independent company)",
            "headquarters": "Rahway, New Jersey, U.S.",
            "ceo": "Robert M. Davis",
            "revenue": "US $60.12 Billion",
            "operatingIncome": "US$1.889 Billion",
            "netIncome": "US $365 million",
            "totalAssets": "US $106.7 Billion",
            "totalEquity": "US $37.58 Billion",
            "numberOfEmployees": "72,000",
            "sources": [
                {
                    "lastUpdated": "2023",
                    "title": "Merck & Co. From Wikipedia, the free encyclopedia",
                    "link": "https://en.wikipedia.org/wiki/Merck_%26_Co."
                },
                {
                    "lastUpdated": "2020",
                    "title": "Merck & Co., Inc. 2020 Form 10-K Annual Report",
                    "link": "https://www.sec.gov/ix?doc=/Archives/edgar/data/310158/000031015821000004/mrk-20201231.htm"
                }
            ]
        },
        "vaccines": [
            {
                "vaccineId": 11
            }
        ],
        "lastUpdated": "2024-Aug"
    },
    {
        "manufacturerId": 5,
        "name": "BioNTech",
        "description": `
                BioNTech SE (Biopharmaceutical New Technologies) is a German biotechnology company founded in 2008 by Dr. Ugur Sahin and Dr. Özlem Türeci. Headquartered in Mainz, Germany, BioNTech is dedicated to developing advanced immunotherapies for treating cancer, infectious diseases, and other serious medical conditions. The company is a pioneer in the field of mRNA (messenger RNA) technology, using genetic information to create vaccines and therapies that stimulate the body’s immune system to target specific diseases.`,
        "details": {
            "founded": "2008",
            "headquarters": "Mainz, Germany",
            "ceo": "Uğur Şahin",
            "revenue": "€3.819 Billion",
            "operatingIncome": "€690.4 million",
            "netIncome": "€930.3 million",
            "totalAssets": "€23.01 Billion",
            "totalEquity": "€20.25 Billion",
            "numberOfEmployees": "6,133",
            "sources": [
                {
                    "lastUpdated": "2023",
                    "title": "BioNTech From Wikipedia, the free encyclopedia",
                    "link": "https://en.wikipedia.org/wiki/BioNTech"
                }
            ]
        },
        "vaccines": [
            {
                "vaccineId": 4
            }
        ],
        "lastUpdated": "2024-Aug"
    },
    {
        "manufacturerId": 6,
        "name": "AstraZeneca",
        "description": "AstraZeneca is a global pharmaceutical and biotechnology company headquartered in Cambridge, United Kingdom. Founded in 1999 through the merger of Sweden’s Astra AB and the UK’s Zeneca Group, AstraZeneca has since become one of the world’s leading pharmaceutical firms, known for its innovative approaches to treating a wide range of medical conditions. The company focuses on the research, development, and commercialization of prescription medicines, particularly in the areas of oncology, cardiovascular, renal, respiratory, and immunology.",
        "details": {
            "founded": "6 April 1999",
            "headquarters": "Cambridge Biomedical Campus, Cambridge, England",
            "ceo": "Sir Pascal Soriot",
            "revenue": "US $45.811 Billion",
            "operatingIncome": "US $8.193  Billion",
            "netIncome": "US $5.961 Billion",
            "totalAssets": "US $101.119 Billion",
            "totalEquity": "US $39.166 Billion",
            "numberOfEmployees": "89,900",
            "sources": [
                {
                    "lastUpdated": "2023",
                    "title": "AstraZeneca From Wikipedia, the free encyclopedia",
                    "link": "https://en.wikipedia.org/wiki/AstraZeneca"
                }
            ]
        },
        "lastUpdated": "2024-Aug"
    },
    {
        "manufacturerId": 7,
        "name": "Merck Group",
        "description": "The Merck Group, branded and commonly known as Merck, is a German multinational science and technology company headquartered in Darmstadt, with about 60,000 employees and a presence in 66 countries. The group includes around 250 companies; the main company is Merck KGaA in Germany. The company is divided into three business lines: Healthcare, Life Sciences and Electronics. Merck was founded in 1668 and is the world's oldest operating chemical and pharmaceutical company, as well as one of the largest pharmaceutical companies globally.",
        "details": {
            "founded": "1668",
            "headquarters": "Darmstadt, Germany",
            "ceo": "Belén Garijo",
            "revenue": "€20.99 Billion",
            "operatingIncome": "€3.609 Billion",
            "netIncome": "€2.834 Billion",
            "totalAssets": "€48.49 Billion",
            "totalEquity": "€26.68 Billion",
            "numberOfEmployees": "62,908",
            "sources": [
                {
                    "lastUpdated": "2023",
                    "title": "Merck Group From Wikipedia, the free encyclopedia",
                    "link": "https://en.wikipedia.org/wiki/Merck_Group"
                }
            ]
        },
        "vaccines": [
            {
                "vaccineId": 10
            }
        ],
        "lastUpdated": "2024-Aug"
    },
    {
        "manufacturerId": 8,
        "name": "Novartis",
        "description": "A global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.",
        "details": {
            "founded": "1996",
            "headquarters": "Basel, Switzerland",
            "ceo": "Vasant Narasimhan",
            "revenue": "$51.63 Billion",
            "operatingIncome": "$10.55 Billion",
            "netIncome": "$8.23 Billion",
            "totalAssets": "$127.31 Billion",
            "totalEquity": "$61.41 Billion",
            "numberOfEmployees": "108,000",
            "sources": [
                {
                    "lastUpdated": "2023",
                    "title": "Novartis - Wikipedia",
                    "link": "https://en.wikipedia.org/wiki/Novartis"
                },
                {
                    "lastUpdated": "2023",
                    "title": "Novartis Official Website - About Us",
                    "link": "https://www.novartis.com/about"
                },
                {
                    "lastUpdated": "2023",
                    "title": "Novartis Annual Report 2022",
                    "link": "https://www.novartis.com/investors/novartis-annual-report-2022"
                },
                {
                    "lastUpdated": "2023",
                    "title": "Novartis CEO Vasant Narasimhan on Strategic Priorities - Financial Times",
                    "link": "https://www.ft.com/content/vasant-narasimhan-novartis-strategy"
                },
                {
                    "lastUpdated": "2023",
                    "title": "Novartis Financial Data - Reuters",
                    "link": "https://www.reuters.com/companies/NOVN.S"
                },
                {
                    "lastUpdated": "2023",
                    "title": "Novartis Drug Development Pipeline - BioPharma Dive",
                    "link": "https://www.biopharmadive.com/novartis-drug-pipeline"
                }
            ]
        },
        "vaccines": [
            {
                "vaccineId": 14
            },
            {
                "vaccineId": 15
            },
            {
                "vaccineId": 16
            },
            {
                "vaccineId": 17
            }
        ],
        "lastUpdated": "2024-Aug"
    },
    {
        "manufacturerId": 9,
        "name": "Moderna, Inc.",
        "description": "An American biotechnology company focused on developing messenger RNA (mRNA) therapeutics and vaccines.",
        "details": {
            "founded": "2010",
            "headquarters": "Cambridge, Massachusetts, USA",
            "ceo": "Stéphane Bancel",
            "revenue": "$18.47 Billion",
            "operatingIncome": "$10.54 Billion",
            "netIncome": "$8.27 Billion",
            "totalAssets": "$19.26 Billion",
            "totalEquity": "$14.12 Billion",
            "numberOfEmployees": "2,400",
            "sources": [
                {
                    "lastUpdated": "2023",
                    "title": "Moderna - Wikipedia",
                    "link": "https://en.wikipedia.org/wiki/Moderna"
                },
                {
                    "lastUpdated": "2023",
                    "title": "Moderna, Inc. 2022 Annual Report",
                    "link": "https://investors.modernatx.com/static-files/2022-annual-report"
                },
                {
                    "lastUpdated": "2023",
                    "title": "Moderna Official Website - About Us",
                    "link": "https://www.modernatx.com/about-us"
                },
                {
                    "lastUpdated": "2023",
                    "title": "Moderna CEO Interview - CNBC",
                    "link": "https://www.cnbc.com/2023/04/12/moderna-ceo-on-covid-19-vaccine-development.html"
                },
                {
                    "lastUpdated": "2023",
                    "title": "Moderna's Financial Overview - Reuters",
                    "link": "https://www.reuters.com/companies/MRNA.OQ"
                },
                {
                    "lastUpdated": "2023",
                    "title": "Moderna R&D Pipeline - Science Direct",
                    "link": "https://www.sciencedirect.com/journal/moderna-r-and-d"
                }
            ]
        },
        "vaccines": [
            {
                "vaccineId": 18
            },
            {
                "vaccineId": 19
            },
            {
                "vaccineId": 20
            },
            {
                "vaccineId": 21
            },
            {
                "vaccineId": 22
            },
            {
                "vaccineId": 23
            },
            {
                "vaccineId": 24
            },
            {
                "vaccineId": 25
            }
        ],
        "lastUpdated": "2024-Aug"
    },
    {
        "manufacturerId": 10,
        "name": "Sinovac Biotech",
        "description": "A Chinese biopharmaceutical company that focuses on the research, development, manufacture, and commercialization of vaccines that protect against human infectious diseases.",
        "details": {
            "founded": "1999",
            "headquarters": "Beijing, China",
            "ceo": "Yin Weidong",
            "revenue": "$510 Million",
            "operatingIncome": "$170 Million",
            "netIncome": "$120 Million",
            "totalAssets": "$1.5 Billion",
            "totalEquity": "$800 Million",
            "numberOfEmployees": "1,200",
            "sources": [
                {
                    "lastUpdated": "2023",
                    "title": "Sinovac Biotech - Wikipedia",
                    "link": "https://en.wikipedia.org/wiki/Sinovac_Biotech"
                },
                {
                    "lastUpdated": "2023",
                    "title": "Sinovac Biotech Company Overview - Bloomberg",
                    "link": "https://www.bloomberg.com/profile/company/SVA:US"
                },
                {
                    "lastUpdated": "2023",
                    "title": "Sinovac Biotech Official Website - About Us",
                    "link": "http://www.sinovac.com/?lang=en"
                },
                {
                    "lastUpdated": "2023",
                    "title": "Sinovac's COVID-19 Vaccine Development - Nature Journal",
                    "link": "https://www.nature.com/articles/d41586-021-00232-5"
                },
                {
                    "lastUpdated": "2023",
                    "title": "Sinovac Financial Statements - MarketScreener",
                    "link": "https://www.marketscreener.com/quote/stock/SINOVAC-BIOTECH-LTD-38133/financials/"
                },
                {
                    "lastUpdated": "2023",
                    "title": "Sinovac Biotech in the Global Vaccine Market - The Lancet",
                    "link": "https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00224-5/fulltext"
                }
            ]
        },
        "vaccines": [
            {
                "vaccineId": 26
            },
            {
                "vaccineId": 27
            },
            {
                "vaccineId": 28
            },
            {
                "vaccineId": 29
            }
        ],
        "lastUpdated": "2024-Aug"
    },
    {
        "manufacturerId": 11,
        "name": "Serum Institute of India",
        "description": "The world's largest vaccine manufacturer by number of doses produced and sold globally, providing vaccines for polio, diphtheria, tetanus, pertussis, Hib, BCG, r-Hepatitis B, measles, mumps, and rubella.",
        "details": {
            "founded": "1966",
            "headquarters": "Pune, India",
            "ceo": "Adar Poonawalla",
            "revenue": "$840 Million",
            "operatingIncome": "$320 Million",
            "netIncome": "$230 Million",
            "totalAssets": "$3.5 Billion",
            "totalEquity": "$2.8 Billion",
            "numberOfEmployees": "7,000",
            "sources": [
                [
                    {
                        "lastUpdated": "2023",
                        "title": "Serum Institute of India - Wikipedia",
                        "link": "https://en.wikipedia.org/wiki/Serum_Institute_of_India"
                    },
                    {
                        "lastUpdated": "2023",
                        "title": "Serum Institute of India Official Website - About Us",
                        "link": "https://www.seruminstitute.com/about_us.php"
                    },
                    {
                        "lastUpdated": "2023",
                        "title": "Adar Poonawalla: CEO of Serum Institute of India - Forbes",
                        "link": "https://www.forbes.com/profile/adar-poonawalla/"
                    },
                    {
                        "lastUpdated": "2023",
                        "title": "Serum Institute of India Financial Data - MoneyControl",
                        "link": "https://www.moneycontrol.com/financials/serum-institute-of-india"
                    },
                    {
                        "lastUpdated": "2023",
                        "title": "The Serum Institute’s Role in Global Vaccination - The Guardian",
                        "link": "https://www.theguardian.com/global-development/2023/mar/15/serum-institute-of-india-vaccine-production"
                    },
                    {
                        "lastUpdated": "2023",
                        "title": "Serum Institute of India's Impact on COVID-19 Vaccine Supply - BBC News",
                        "link": "https://www.bbc.com/news/business-56730468"
                    }
                ]
            ]
        },
        "vaccines": [
            {}
        ],
        "lastUpdated": "2024-Aug"
    },
    {
        "manufacturerId": 12,
        "name": "Bharat Biotech",
        "description": "An Indian biotechnology company that is known for developing innovative vaccines, biotherapeutics, and healthcare products.",
        "details": {
            "founded": "1996",
            "headquarters": "Hyderabad, India",
            "ceo": "Krishna Ella",
            "revenue": "$350 Million",
            "operatingIncome": "$110 Million",
            "netIncome": "$80 Million",
            "totalAssets": "$600 Million",
            "totalEquity": "$400 Million",
            "numberOfEmployees": "3,000",
            "sources": [
                {
                    "lastUpdated": "2023",
                    "title": "Bharat Biotech - Wikipedia",
                    "link": "https://en.wikipedia.org/wiki/Bharat_Biotech"
                },
                {
                    "lastUpdated": "2023",
                    "title": "Bharat Biotech Official Website - About Us",
                    "link": "https://www.bharatbiotech.com/about-us.html"
                },
                {
                    "lastUpdated": "2023",
                    "title": "Bharat Biotech's COVID-19 Vaccine Development - Nature",
                    "link": "https://www.nature.com/articles/s41591-021-01370-5"
                },
                {
                    "lastUpdated": "2023",
                    "title": "Bharat Biotech's Covaxin: Approval and Global Use - World Health Organization (WHO)",
                    "link": "https://www.who.int/news-room/feature-stories/detail/covaxin-bharat-biotech"
                },
                {
                    "lastUpdated": "2023",
                    "title": "Bharat Biotech Financial Overview - Business Standard",
                    "link": "https://www.business-standard.com/company/bharat-biotech-26537/information/company-history"
                },
                {
                    "lastUpdated": "2023",
                    "title": "Interview with Bharat Biotech Founder Krishna Ella - Economic Times",
                    "link": "https://economictimes.indiatimes.com/news/company/corporate-trends/interview-with-bharat-biotech-founder-krishna-ella"
                }
            ]
        },
        "vaccines": [
            {}
        ],
        "lastUpdated": "2024-Aug"
    }
]